SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-18-012612
Filing Date
2018-09-17
Accepted
2018-09-17 06:27:30
Documents
43
Period of Report
2018-09-17

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 6-K f6k091718a1_kitovpharma.htm 6-K/A 12360
2 f6k0918ex99-1_kitovpharma.htm EX-99.1 334040
  Complete submission text file 0001213900-18-012612.txt   2066397

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE ktov-20180630.xml EX-101.INS 340423
4 XBRL SCHEMA FILE ktov-20180630.xsd EX-101.SCH 43542
5 XBRL CALCULATION FILE ktov-20180630_cal.xml EX-101.CAL 36134
6 XBRL DEFINITION FILE ktov-20180630_def.xml EX-101.DEF 68522
7 XBRL LABEL FILE ktov-20180630_lab.xml EX-101.LAB 261421
8 XBRL PRESENTATION FILE ktov-20180630_pre.xml EX-101.PRE 155829
Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101
Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121
Kitov Pharma Ltd. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-37643 | Film No.: 181072360
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1